Invitation to Conference Call Regarding Promore Pharma's Interim Report for the First Quarter 2022

ACCESSWIRE
13 May 2022, 19:01 GMT+10

STOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)

STOCKHOLM, 13 May 2022 - Promore Pharma AB (publ) publishes its interim report for the first quarter 2022 on 17 May 2022.

The same day the company will host a webcast telephone conference at 16.00 CET, with President and CEO Jonas Ekblom and CFO Erik Magnusson, where an update for the quarter and upcoming activities. After the presentation there will be a Q&A session. The conference call will be held in English and can be accessed via computer, tablet, or telephone.

The number of attendees is limited, please register for the conference in advance on the following link:

https://attendee.gotowebinar.com/register/4045498425908535564

The conference call will be recorded and made available on the company´s website after the call, and on Västra Hamnen Corporate Finance Youtube channel.

About Promore Pharma

Promore Pharma is a biopharmaceutical company that develops pharmaceutical product candidates for bioactive wound care. Today, the company has two drug candidates in late clinical development stages, that are based on endogenous peptides, and thus have a strong safety profile. These two products are intended for treatment of chronic wounds, and prevention of scarring on the skin and other tissues. The company is listed on the Nasdaq First North Growth Market.

For additional information, please contact

Jonas Ekblom, CEO
Phone: [+46] 736 777 540
E-mail: jonas.ekblom@promorepharma.com

Erik Magnusson, CFO
Phone: [+46] 708 565 245
E-mail: erik.magnusson@promorepharma.com

Promore Pharmas Certified Adviser is Erik Penser Bank
Tel: [+46] 8-463 83 00
E-mail: certifiedadviser@penser.se

Attachments

Invitation to Conference Call regarding Promore Pharma's Interim Report for the First Quarter 2022

SOURCE: Promore Pharma

View source version on accesswire.com:
https://www.accesswire.com/701250/Invitation-to-Conference-Call-Regarding-Promore-Pharmas-Interim-Report-for-the-First-Quarter-2022

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.

More Information

57 ℉

Fair in Cleveland/Burke

Business

Section

Hang Seng jumps sharply on possible China move to relax tech reform

SYDNEY, NSW, Australia - A potential easing of the Chinese government's crackdown on technology companies drove stocks in Hong Kong ...

Nepal to get free 21.9% of 490mw electricity every month

KATHMANDU, Nepal - The governments of Nepal and India have signed a bilateral memorandum of understanding for the construction of ...

Kia reports second most electric car sales in US, Ford close behind

LOS ANGELES, California: Kia has become the second largest manufacturer of electric vehicles sold in the United States, second only ...

U.S. stock markets undermined by weak Chinese data

NEW YORK, New York - Weak economic news out of China undermined stocks on Wall Street on Monday. The major ...

Braking problems cause Mercedes-Benz to issue do-not-drive order

ATLANTA, Georgia: Mercedes-Benz USA has requested drivers to stop driving some of their autos immediately due to braking problems.The announcement ...